Tesamorelin Research Overview: GHRH Analog for Lipodystrophy Studies
Tesamorelin is a synthetic 44-amino-acid GHRH analog with an FDA-approved indication for HIV-associated lipodystrophy. This guide covers its pharmacology, the strong evidence base for visceral adipose tissue research, and the gap between labeled use and broader online applications.
Sections
Chemical Structure and Pharmacology
Mechanisms Studied in Research
Ready to explore our peptides?
Browse our full range of research-grade peptides with fast EU shipping.
Key Research Applications
Community Use vs Evidence Base
Storage and Regulatory Status
Stay up to date with peptide research
Get the latest research findings, product updates, and exclusive offers delivered to your inbox.
Ready to get started?
Browse our full range of research-grade peptides with fast EU shipping.